Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVES We conducted 2 studies to determine the impact of text message immunization reminder-recalls in an urban, low-income… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
BACKGROUND Human immunodeficiency virus (HIV)-infected children are at increased risk of meningococcal infection and poor… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
OBJECTIVE To compare the immunogenicity of 1 vs 2 doses of meningococcal polysaccharide conjugate vaccine (MCV4) in youth… (More)
Is this relevant?
2011
2011
BACKGROUND Despite national recommendations, as of 2009 human papillomavirus (HPV) vaccination rates were low with < 30% of… (More)
  • table 1
  • table 2
Is this relevant?
2010
2010
BACKGROUND A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
The persistence of human bactericidal activity (hSBA) responses in adolescents was assessed 22 months after vaccination with one… (More)
Is this relevant?
2010
2010
BACKGROUND Routine administration of quadrivalent meningococcal conjugate vaccine to adolescents and certain high risk groups is… (More)
Is this relevant?
2008
2008
  • MMWR. Morbidity and mortality weekly report
  • 2008
At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine… (More)
Is this relevant?
2007
2007
PURPOSE To describe the uptake of meningococcal conjugate vaccine (MCV4) in Michigan adolescents following its approval in… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi… (More)
Is this relevant?